Clinical Trial: Using a Vaccine PVX-410 with Citarinostat +/- Lenalidomide for Smoldering Multipl...
Mar 08, 2019
A Phase I study of a vaccine called PVX-410 for patients with moderate/high risk Smoldering Multiple Myeloma is open. PVX-410 is...
LIFE WITH MYELOMA
Mar 18, 2019
You have cancer. No one ever expects to hear those...
MUSCLES FOR MYELOMA
Bike the Coast June 2019 – An Epic Cycling Event From San Francisco to San Diego to Fund My...
Feb 27, 2019
Join us this summer to Bike the Coast to raise funds for multiple myeloma research! This epic event will include a ride from San Francisco to San Diego – 100 miles a day for 6 days. Ride as much or as little as you’d like. We have each...
Clinical Trial: Overall Survival Lengthened for Relapsed/Refractory Myeloma Patients Using CLR 131 Cancer-Targeted Th...
Feb 02, 2019
Myeloma patients who had relapsed after receiving both a proteasome inhibitor (like Velcade) and immunomodulator (like Revlimid) participated in a Phase I study of a new drug called CLR 131 and experienced an average 22 month overall...
Find financial resources like housing, prescription and patient assistance programs and other helpful links that will guide you through your myeloma care.
Patients who are seen by myeloma specialists live longer. Find a myeloma specialists closest to you and add them to your care team for your best outcomes.
Today's myeloma therapies are yesterday's clinical trials and if more patients joined, we could accelerate a cure.Find a trial that's right for you using a myeloma clinical trial finder called SparkCures.
MYELOMA CROWD RESEARCH INITIATIVE
The Myeloma Crowd Research Initiative (MCRI) is a new approach to funding cancer research; combining the skill and knowledge of leading myeloma specialists with the patient perspective and supportive patient social communities to select and fund promising research projects in myeloma. The goal of the MCRI is to find and fund a cure for multiple myeloma.Learn More >
Thanks to our site sponsors: